Ensysce Biosciences Inc (ENSC) Stock Analysis

Ensysce Biosciences Inc (ENSC) is a publicly traded company in the HEALTHCARE sector. It trades at $0.26, carries a market capitalization of $4.11M. This page summarizes the public market data, fundamentals, and frequently asked questions for ENSC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.26
• Market Cap: $4.11M
• EPS: $-3.11
• 52-Week High: $2.75
• 52-Week Low: $0.23

Market Sentiment

Ensysce Biosciences Inc currently has a Bearish sentiment score of -0.63.

About Ensysce Biosciences Inc

Ensysce Biosciences Inc. is a clinical-stage biotechnology company headquartered in La Jolla, California, dedicated to pioneering transformative prescription drug solutions that tackle critical unmet medical needs. With a focus on innovative drug delivery technologies, Ensysce is actively developing pain management therapies aimed at mitigating the risks associated with opioid dependence. The company's commitment to pharmaceutical research and development underscores its potential to revoluti...

GNG Research Analysis

GNG Research scores Ensysce Biosciences Inc (ENSC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ENSC.

Frequently Asked Questions

Does ENSC pay dividends?

Ensysce Biosciences Inc (ENSC) does not currently pay a regular dividend.

What is ENSC's market cap?

Ensysce Biosciences Inc (ENSC) has a market capitalization of $4.11M with a current stock price of $0.26.